SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-676826
Filing Date
2016-08-09
Accepted
2016-08-09 16:32:32
Documents
3
Period of Report
2016-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d239680d8k.htm 8-K 12765
2 PRESS RELEASE ISSUED BY THE COMPANY ON AUGUST 9, 2016 d239680dex991.htm EX-99.1 73384
3 GRAPHIC g239680g0809234959235.jpg GRAPHIC 5335
  Complete submission text file 0001193125-16-676826.txt   95014
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 161818417
SIC: 2834 Pharmaceutical Preparations